Dal Negro R W, Zoccatelli O, Pomari C, Turco P, Monici Pretti P
Int J Clin Pharmacol Ther Toxicol. 1986 Jun;24(6):323-5.
The efficacy of procaterol, a new selective beta 2-stimulant (by pressurized aerosol), and its protection against the effects of non-specific bronchial stimulation (fog test) was evaluated in ten hyperreactive seasonal atopics in an open trial of twelve days duration. Preliminary results had proved that single (10 micrograms) and repetitive (10 micrograms t.i.d.) doses of procaterol induced a strong bronchodilation. Accordingly the pre-medication with procaterol (10 micrograms) completely prevents the flow limitation subsequent to the non-specific bronchial stimulation.
在一项为期12天的开放性试验中，对10名季节性高反应性特应性患者评估了新型选择性β2激动剂丙卡特罗（通过压力气雾剂）的疗效及其对非特异性支气管刺激（雾化试验）影响的保护作用。初步结果证明，单次（10微克）和重复（每日三次，每次10微克）剂量的丙卡特罗可引起强烈的支气管扩张。因此，丙卡特罗（10微克）预处理可完全预防非特异性支气管刺激后的气流受限。
